You are currently viewing a new version of our website. To view the old version click .

Advances in the Diagnosis and Treatment of Prostate Cancer: From Biomarkers to Precision Surgery

This special issue belongs to the section “Cancer Therapy“.

Special Issue Information

Dear Colleagues,

This Special Issue will focus on recent innovations and clinical advances in prostate cancer, spanning early detection, risk stratification, novel imaging modalities, minimally invasive and robotic surgical techniques, and the integration of molecular biomarkers into personalized treatment strategies. Emphasis will be placed on multidisciplinary approaches and the evolving role of artificial intelligence and genomics in clinical decision making.

For this Special Issue, original research articles and reviews are welcome. Research areas may include (but are not limited to) the following:

  • Prostate cancer;
  • Precision medicine;
  • Molecular biomarkers;
  • Risk stratification;
  • Robotic surgery;
  • Artificial intelligence;
  • Genomics;
  • Personalized treatment;
  • Imaging modalities;
  • Multidisciplinary approach.

We look forward to receiving your contributions.

Dr. Stamatios N. Katsimperis
Dr. Lazaros Tzelves
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • prostate cancer
  • precision medicine
  • molecular biomarkers
  • risk stratification
  • robotic surgery
  • artificial intelligence
  • genomics
  • personalized treatment
  • imaging modalities
  • multidisciplinary approach

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Published Papers

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Cancers - ISSN 2072-6694